Scientists are developing a skin patch to cure deadly peanut allergies, much like the nicotine patch. This would be huge for those suffering from this terrible allergy and their families. Research is still in the early stages, but scientists are hopeful that this new treatment will be available shortly.
Apart from developing a skin patch, scientists are also looking into other potential treatments for peanut allergies. These treatments include giving small doses of peanut protein to children who are allergic to peanuts and using a medication called omalizumab, which is already used to treat asthma.
The patch containing pieces of peanut protein is a way for the wearer to develop their resistance.
The skin patch works because it can expose people to small amounts of proteins and help train the immune system not to respond so strongly after coming into contact with them.
Antibodies show that they can recognize a protein found in peanut butter, perceive it as non-threatening and stop overreacting because of an antagonist.
The skin patch has already been tested on mice, and the results have proved promising. The dermatologist who developed this idea, Dr. Cathryn Nagler, hopes to implement the new treatment in clinical trials in the next few years.
She says that “it’s a matter of life or death” for food allergy patients who are at risk of anaphylaxis when peanuts are present.
Interval reports are exceptionally encouraging.
The Viaskin Peanut patch is a new treatment for peanut allergies in children. It’s being studied as part of an ongoing multi-center clinical trial, which will evaluate its efficacy and safety among 54 randomized patients aged 5 to 17 years old with confirmed food allergy symptoms due to their allergic reaction when exposed only at point-blank range or touching certain foods like peanuts (or other legumes). The six-month interim data show no dropouts from this study since it does not cause any severe side effects, including death from anaphylactic shock – something parents fear most about having severe reactions after coming into contact with allergens such as sandwiches made gluten-free loaves of bread.
“The interim data look promising. There were no adverse events, and there was a trend of improvement in the symptoms score,” said study investigator Dr. David Fleischer, MD, Co-Director of the Food Allergy Center at National Jewish Health in Denver. We see whether they are maintained when patients are exposed to peanut protein through the skin.
Right now, no known treatment for nut sensitivity.
Professor Christophe Dupont, the co-founder of DVB Technologies, which manufactures the patch, said that since these proteins stay on our skin and give us a chance to acclimate while they’re still in place slowly, it’s doubtful for them to get into the bloodstream.
However, it is easy to be exposed to allergens through the skin if one doesn’t wash properly after coming into contact with them, so everyone must take necessary precautions.
The Viaskin Peanut patch is not yet approved for those suffering from nut allergies; however, clinical trials are currently underway, and more information on this treatment will be made available as it becomes available.